Scholars Central

Conference abstractPublished 7 Dec 2015

Stories Behind The Cocktail and Synergism

Authors: Ting-Chao Chou

PD Science LLC, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The therapy of AIDS and cancer rarely used single drugs, rather have used two or more drug combinations. Drug combination may provide benefits of synergistic therapeutic effect, as well as reduced toxicity, minimized or delayed development of drug resistance, or allowed attacking multiple receptor or etiological targets. The important basic requirements for these aims are: i) Definition of synergism and its quantitative determination using the Combination Index (CI<1); ii) Simple and efficient experiment design using small number of data points and small number patients in phase-I clinical trial design using the mass-action law based âÂ?Â?minimum of two-data point theoryâÂ? for dose and effect dynamics; iii) The theoretical basis for the Combination Index for 3 or more drugs combinations using the âÂ?Â?PolygonogramâÂ?. Questions to be asked are: How to assess combo synergy quantitatively for 2 or more drugs? Are the combos on the market the best in synergy? Do peer reviewers, journal editors and governmental regulatory agencies really understand what synergy is? These issues will be discussed and the answers will be provided.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Antivirals & Antiretrovirals.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Antivirals & Antiretrovirals
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Ting-Chao Chou”